Beacon Biosignals, a leader in AI-driven neurophysiology and precision drug development, today announced a collaboration with Harmony Biosciences (Nasdaq: HRMY), a pharmaceutical company dedicated to ...

Three world-leading nuclear medicine organizations--the SNMMI Clinical Trials Network (SNMMI-CTN), the Australasian Radiopharmaceutical Trials Network (ARTnet), and the European Association of Nuclear ...

The vast majority of asset management companies today use model portfolios. One question we’ve been asked many times is whether ValuEngine stock ratings can be used for portfolio management or merely ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

Fed's QT halt supported by most policymakers, effective Dec. 1 QT aimed to draw down panemic era liquidity provisions Large balance sheet raises concerns, but seen as necessary by some officials Nov ...

The Federal Reserve will end its current round of quantitative tightening on December 1, signaling a potential shift toward quantitative easing. Since 2009, the Fed has managed monetary policy through ...

In an economic boon for the city, a massive plot of empty fields near the regional wastewater plant in North San Jose could become a new data center and advanced manufacturing campus, potentially ...

KSHB 41 reporter Isabella Ledonne reports on stories about government accountability. This story follows the Data, Dollars and Demand series and Isabella's extensive reporting on data centers in the ...

Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in Sjögren’s disease, the pharma reported at the American College of ...

The Trump administration is hailing a medication called leucovorin for reducing some autism symptoms, but experts who research or treat autism almost uniformly agree the medication should be studied ...